Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,195 | 22 | 45.7% |
| Food and Beverage | $20,613 | 800 | 40.6% |
| Travel and Lodging | $5,192 | 30 | 10.2% |
| Consulting Fee | $908.00 | 1 | 1.8% |
| Education | $804.66 | 15 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $27,891 | 192 | $0 (2024) |
| Indivior Inc. | $5,159 | 91 | $0 (2024) |
| ABBVIE INC. | $3,388 | 68 | $0 (2024) |
| Alkermes, Inc. | $2,633 | 109 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $2,090 | 75 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,990 | 55 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $1,722 | 49 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,304 | 45 | $0 (2024) |
| ITI, Inc. | $1,217 | 59 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $1,009 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,890 | 366 | Teva Pharmaceuticals USA, Inc. ($19,495) |
| 2023 | $16,463 | 306 | Teva Pharmaceuticals USA, Inc. ($7,690) |
| 2022 | $4,362 | 157 | Janssen Pharmaceuticals, Inc ($841.94) |
| 2021 | $997.62 | 39 | Alkermes, Inc. ($240.78) |
All Payment Transactions
868 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: CNS | ||||||
| 12/23/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $23.70 | General |
| 12/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $36.13 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.99 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.68 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: CNS | ||||||
| 12/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: CNS | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.28 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: CNS | ||||||
| 12/03/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.72 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Central Nervous System | ||||||
| 11/27/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: CNS | ||||||
| 11/26/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 41 | 156 | $16,712 | $10,392 |
| 2022 | 1 | 33 | 83 | $8,664 | $6,036 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 156 | $16,712 | $10,392 | 62.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 83 | $8,664 | $6,036 | 69.7% |
About Thy Lam
Thy Lam is a Registered Nurse healthcare provider based in Vista, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2019. The National Provider Identifier (NPI) number assigned to this provider is 1083277255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thy Lam has received a total of $50,713 in payments from pharmaceutical and medical device companies, with $28,890 received in 2024. These payments were reported across 868 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,195).
As a Medicare-enrolled provider, Lam has provided services to 74 Medicare beneficiaries, totaling 239 services with total Medicare billing of $16,428. Data is available for 2 years (2022–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health
- Location Vista, CA
- Active Since 04/15/2019
- Last Updated 03/05/2021
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1083277255
Products in Payments
- UZEDY (Drug) $12,597
- Austedo XR (Drug) $12,143
- PERSERIS (Drug) $5,159
- VRAYLAR (Drug) $3,388
- AUSTEDO (Drug) $2,531
- INGREZZA (Drug) $2,046
- INVEGA SUSTENNA (Drug) $1,928
- CAPLYTA (Drug) $1,687
- ARISTADA (Drug) $1,608
- HETLIOZ (Drug) $1,246
- REXULTI (Drug) $1,025
- ABILIFY MAINTENA (Drug) $647.85
- LYBALVI (Drug) $601.52
- FANAPT (Drug) $475.76
- LATUDA (Drug) $348.42
- Auvelity (Drug) $344.55
- VIVITROL (Drug) $274.75
- ABILIFY ASIMTUFII (Drug) $194.02
- Vivitrol (Drug) $149.12
- NUPLAZID (Drug) $64.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Vista
Donna Clark, Gnp, GNP
Registered Nurse — Payments: $582.60
Ms. Jessica Hernandez
Registered Nurse — Payments: $134.66
Lauren Chew, Np, NP
Registered Nurse — Payments: $43.24
Dr. Melanie Logue, Phd, Dnp, Aprn, Cfnp, PHD, DNP, APRN, CFNP
Registered Nurse
Mrs. Rebecca Levy, Bsn, BSN
Registered Nurse
Mary Joswig, Fnp, FNP
Registered Nurse